from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3835/-

LFCtreatmentdescriptionclass of inhibitor

-0.798

Amikacinug/mL Amikacintranslation

-0.843

Cap5-10ug/mL Capreomycintranslation

-2.585

Rox10-50 ug/mL Roxithromycintranslation

-0.049

SM2-5 ug/mL Streptomycintranslation

-1.164

Tet5-10 ug/mL Tetracyclinetranslation

-0.890

Rif0.2-5ug/mL Rifampicintranscription

-0.120

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.933

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.075

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.337

CPZ10-50 ug/mL Chlorpromazinerespiration

1.453

Clofazimine10-13 ug/mL Clofaziminerespiration

0.927

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.097

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.866

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.606

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.012

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.203

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.699

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.876

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.066

KCN5-20 ug/mL Potassium cyaniderespiration

0.900

NaN30.2-2 mM Sodium aziderespiration

0.975

Nigericin50 uM Nigericinrespiration

-0.488

TRC10-150 ug/mL Triclosanrespiration

-0.794

TRZ10-25 ug/mL Thioridazinerespiration

-1.110

Valinomycin0.5-10 uM Valinomycinrespiration

0.697

ZnSO42 mM ZnSO4respiration

0.581

menadione6-10 ug/mL Menadionerespiration

0.812

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.350

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.429

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.614

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.585

NRP_1Non-replicating persistence stage 1dosRassociated

-0.191

Amp0.2mg/mL AmpicillincellWall

0.440

Cephalexin20-100 ug/mL CephalexincellWall

0.842

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.902

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.080

EMB10-20 ug/mL EthambutolcellWall

0.036

Eta12-40 ug/mL EthionamidecellWall

-0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

0.267

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.395

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.985

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.415

BZA0.12 mg/mL BenzamidearomaticAmides

-0.768

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.845

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.728

H2O24 mM hydrogen peroxideDNAdamaging

0.339

Levo10 ug/mL LevofloxacinDNAdamaging

-0.728

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.297

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.002

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.934

UVUV-irradiationDNAdamaging

-0.410

ARP41-4 ug/mL Antitubercular compound ARP4?

0.670

Antimycin12.5-50 ug/mL Antimycin A?

0.782

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.766

PA_110-50 ug/mL Antitubercular compound PA-1?

0.739

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.315

PA8240.2-2 ug/mL PA-824?

0.681

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.252

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.793

Verapamil50 uM Verapamil?

0.371

mercaptoethanol2 mM 2-Mercaptoethanol?

1.151

methoxatin10-20 ug/mL Methoxatin?